Global Angioplasty Balloons Market
Angioplasty Balloons Market Size And Forecast
According to Verified Market Research, the Angioplasty Balloons Market was valued at USD 2.16 Billion in 2018 and is projected to reach USD 2.77 Billion by 2026, growing at a CAGR of 3.17% from 2019 to 2026.
Global Angioplasty Balloons Market Outlook
Rising geriatric population results in an exponential increase in coronary heart disease prevalence, which in turn fueling the angioplasty balloon market. The factors such as rising prevalence lifestyle-related disorders and increasing preference for minimally invasive procedures are further expected to boost the market. Moreover, the mergers and acquisitions, new product launches are also expected to drive the market growth. For instance, in December 2017, C.R. Bard, Inc. was acquired by BD (Becton, Dickinson and Company) expanding BDs product offerings globally. On the other hand, high costs associated with the procedure and strict safety regulations might impede the market growth.
Global Angioplasty Balloons Market Competitive Landscape
The Global Angioplasty Balloons Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as Medtronic PLC, Boston Scientific Corporation, Cardinal Health (Cordis), Spectranetics Corp., Becton, Dickinson and Company (C. R. Bard, Inc.), ENDOCOR GmbH, Abbott Laboratories, Johnson & Johnson, and Cook Medical, Inc.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.